Kevin Schutz

Director at Adimab

Kevin Schutz is a highly experienced professional in antibody discovery, with over 10 years of experience in the field. With a Ph.D. in Molecular and Cellular Biology, Kevin has held various roles in companies such as Adimab, University of Washington, OHSU, and Howard Hughes Medical Institute. Kevin has expertise in antibody discovery campaign management, next-generation sequencing, antibody library construction, technical training, and SOP development. Kevin is known for their exceptional contributions to the field of antibody engineering.

Links

Previous companies

University of Washington logo
Howard Hughes Medical Institute logo

Timeline

  • Director

    July 1, 2023 - present

  • Associate Director

    July, 2021

  • Group Leader

    January, 2020

  • Scientist II, Antibody Engineering

    April, 2010

View in org chart